.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Healthtrust
Teva
Covington
Federal Trade Commission
Johnson and Johnson
US Department of Justice
Baxter
Daiichi Sankyo
Farmers Insurance

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075633

« Back to Dashboard
NDA 075633 describes CLOBETASOL PROPIONATE (EMOLLIENT), which is a drug marketed by Teligent Pharma Inc, Fougera Pharms, Novast Labs Ltd, and Taro, and is included in four NDAs. It is available from four suppliers. Additional details are available on the CLOBETASOL PROPIONATE (EMOLLIENT) profile page.

The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for 075633

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 075633

Medical Subject Heading (MeSH) Categories for 075633

Suppliers and Packaging for NDA: 075633

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE (EMOLLIENT)
clobetasol propionate
CREAM;TOPICAL 075633 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1297 51672-1297-1 1 TUBE in 1 CARTON (51672-1297-1) > 15 g in 1 TUBE
CLOBETASOL PROPIONATE (EMOLLIENT)
clobetasol propionate
CREAM;TOPICAL 075633 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1297 51672-1297-2 1 TUBE in 1 CARTON (51672-1297-2) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:May 17, 2000TE:AB2RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Fuji
Dow
US Department of Justice
US Army
Deloitte
Moodys
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot